Immunoscreening protocols for the identification of clinically useful antibodies and antigens

Expert Opinion on Investigational Drugs

Volumn 7, Issue 3, 1998, Pages 373-389

  Mukerjee, S ^a   McKnight, M E ^a   Glassy, M C ^a  

^a Novopharm Biotechn Inc   (United States)

Author keywords

Cancer; Cell markers; Immunoassay; Monoclonal antibodies

Indexed keywords

ANTIGEN;

ANTIBODY COMBINING SITE; ANTIGEN ANTIBODY REACTION; BREAST CANCER; CANCER; COMPLEMENT FIXATION TEST; COUNTER IMMUNOELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETIC DISORDER; HEMAGGLUTINATION; HUMAN; IMMUNOASSAY; IMMUNOBLOTTING; IMMUNODIFFUSION; IMMUNOELECTROPHORESIS; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LATEX AGGLUTINATION TEST; LEUKEMIA; LYMPHOMA; MELANOMA; NEPHELOMETRY; PANCREAS CANCER; PROSTATE CANCER; REVIEW; TECHNIQUE;

EID: 0031929960     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.7.3.373     Document Type: Review

References (140)